NutraIngredients: Is perimenopause finally becoming its own category? (Sep 15 2026)
Tier 2: Professional organization or credentialed expert guidance
Publisher: NutraIngredients.com · Published: September 17, 2026 ·
Accessed: September 17, 2026
Visit the source ↗
Claims this source supports
- A large direct-to-consumer supplement brand launched a perimenopause-specific, hormone-free supplement on Sep 15 2026, built around a patented standardized shatavari extract combined with DIM, evening primrose oil and vitamin B6.
- The brand states that hormone therapy is the right choice for some women but not everyone can or wants to use it, positioning the product alongside rather than against hormone therapy.
- The company's own science lead names the aisle's credibility problems as proprietary blends that hide dose, a single small study stretched into a sweeping claim, and traditional use treated as clinical proof.
- The brand reports its own consumer research finding that more than half of women are not satisfied with available perimenopausal solutions.
- The claimed studied effects in perimenopausal women are mood, hot flashes, night sweats and sleep in as little as four weeks, and vaginal dryness and fatigue in as little as eight weeks.